MALVERN, Pa., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage
biotechnology company, will release its third quarter financial results before the market open on November 7, 2017
Management will conduct a conference call at 8:00 AM ET that day to discuss the Company’s financial results and
provide a general business update. A live webcast of the event can be accessed on the Events and Presentations page on the
Investors section of the Aclaris website at http://www.aclaristx.com/events-and-webcasts. A replay of the webcast will be archived
on the Aclaris website following the event.
To participate on the live call, please dial (844) 776-7782 (domestic) or (661) 378-9535 (international), and reference
conference ID 99295180 prior to the start of the call.
About Aclaris
Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led biotechnology company focused on identifying, developing and
commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic
dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting the Aclaris website at
www.aclaristx.com.
Contact:
Aclaris Contact
Michael Tung, M.D.
Investor Relations
484-329-2140
mtung@aclaristx.com
Media Contact
Mariann Caprino
TogoRun
917-242-1087
M.Caprino@togorun.com
